Skip to content

Interject M00518260Recalls & reported problems

Boston Scientific Corporation · Injection Therapy Needle Catheter · Class 2

All models of Interject (9)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08714729415107), received between Apr 12, 2018 and Apr 12, 2018 — classified as 1 malfunction.

The most frequently reported specific device problem is “Occlusion Within Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Occlusion Within Device1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 12, 2018Occlusion Within Device; Occlusion Within Device

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN INTERJECT¿ NEEDLE WAS USED IN A PROCEDURE PERFORMED ON (B)(6) 2018. ACCORDING TO THE COMPLAINANT, THE DEVICE HAS AN OBSTRUCTED LUMEN. ATTEMPTS TO GAIN FURTHER INFORMATION REGARDING THE EVENT HAVE BEEN UNSUCCESSFUL TO DATE, SHOULD ANY RELEVANT INFORMATION BE PROVIDED, A SUPPLEMENTAL MDR WILL BE FILED.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 7426916 ↗

Other Biopsy needle devices

All Biopsy needle devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page